share_log

Chemomab Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Moses Alan Charles

SEC ·  Mar 23, 2023 07:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more